TrialMolecular neurobiology2021

High Genetic Addiction Risk Score (GARS) in Chronically Prescribed Severe Chronic Opioid Probands Attending Multi-pain Clinics: an Open Clinical Pilot Trial.

Mark Moran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.